sb 202190 has been researched along with Leukemia P388 in 1 studies
4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)imidazole: structure given in first source; inhibits p38 MAP kinase
Leukemia P388: An experimental lymphocytic leukemia originally induced in DBA/2 mice by painting with methylcholanthrene.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fujihara, M | 1 |
| Ikebuchi, K | 1 |
| Maekawa, TL | 1 |
| Wakamoto, S | 1 |
| Ogiso, C | 1 |
| Ito, T | 1 |
| Takahashi, TA | 1 |
| Suzuki, T | 1 |
| Sekiguchi, S | 1 |
1 other study available for sb 202190 and Leukemia P388
| Article | Year |
|---|---|
Lipopolysaccharide-induced desensitization of junB gene expression in a mouse macrophage-like cell line, P388D1.
Topics: Animals; Benzoquinones; Calcium-Calmodulin-Dependent Protein Kinases; Dose-Response Relationship, Im | 1998 |